Kiora Pharmaceuticals joins Global Genes' RARE-X Vision Consortium.

Kiora Pharmaceuticals has joined the Global Genes RARE-X Vision Consortium to collaborate on research and development of therapies for rare ocular disorders. The consortium aims to identify clinical trial-ready populations, ensure meaningful outcome measures, and accelerate the development of clinical trials. Data collected will be available in an open-source environment to promote pre-competitive collaboration and overcome shared challenges in drug development.